Top Story

FDA warns against laparoscopic power morcellation for hysterectomy, myomectomy

November 24, 2014

The FDA today released an “immediately in effect” guidance that recommends laparoscopic power morcellators list a boxed warning and two contraindications on the label due to the risk for the device to disseminate unsuspected uterine cancer.

“The FDA’s primary concern is the safety and well-being of patients, and taking these steps will help the agency’s safety recommendations to be implemented as quickly as possible,” William Maisel, MD, MPH, deputy director for science and chief scientist at the FDA’s Center for Devices and Radiological Health, said in a press release. “Updating the device label with a boxed warning and contraindications will provide clinicians and patients with critical information about the risk of spreading cancerous tissue when these procedures are performed.”

FDA News

FDA grants breakthrough therapy designation to JCAR015 for ALL

November 24, 2014
The FDA granted breakthrough therapy designation to JCAR015, a chimeric antigen receptor-modified T-cell therapy candidate, for the treatment of patients with…
Meeting News Coverage

Postoperative radiation extended survival in resected NSCLC

November 24, 2014
Postoperative radiotherapy improved survival by approximately 4 months in patients with resected non–small cell lung cancer with pathologically involved N2 lymph nodes…
Institution Notes

UC Davis appoints chair of department of public health sciences

November 23, 2014
Brad Pollock, PhD, MPH, has been named chair of the department of public health sciences at UC Davis School of Medicine. Pollock, whose research focuses on the incidence…
Institution Notes

NYU Langone names cancer center director

November 22, 2014
Benjamin G. Neel, MD, PhD, has been named director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center.The appointment will be effective Jan. 1.
More News Headlines »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »